Literature DB >> 6887974

Significance of proteinuria on the outcome of renal function in patients with focal segmental glomerulosclerosis.

J A Velosa, K E Holley, V E Torres, K P Offord.   

Abstract

Kidney survival analysis was performed for 64 patients with focal segmental sclerosis to ascertain whether the degree of proteinuria and other factors determined at the time of renal biopsy might be associated with progression to end-stage renal failure. On the basis of urinary excretion of protein, which was measured in 63 of the 64 patients, three groups of patients were identified: 15 patients (group A) had asymptomatic proteinuria (less than 3.5 g/24 h), 38 patients (group B) had nephrotic proteinuria (3.5 to 14 g/24 h), and 10 patients (group C) had massive proteinuria (more than 14 g/24 h). Kidney survival curves showed that the median time from biopsy to end-stage renal failure was more than 11, 7, and 3 years for groups A, B, and C, respectively. Thus, patients with massive proteinuria had an accelerated course to renal failure as compared with other nephrotic patients who had a lesser degree of proteinuria (P = 0.014) and patients who had asymptomatic proteinuria (P less than 0.001). Higher initial serum creatinine levels and severe tubulointerstitial damage were associated with a shorter time to end-stage renal failure. Age at onset and at biopsy, systolic and diastolic blood pressure, serum albumin and cholesterol, percentage of sclerotic glomeruli, mesangial proliferation, hyalinosis, vascular sclerosis, and initial response to prednisone were not associated with the time to end-stage renal failure when each of these variables was considered separately.

Entities:  

Mesh:

Year:  1983        PMID: 6887974

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  18 in total

1.  Differential risk of remission and ESRD in childhood FSGS.

Authors:  Debbie S Gipson; Hyunsook Chin; Trevor P Presler; Caroline Jennette; Maria E Ferris; Susan Massengill; Keisha Gibson; David B Thomas
Journal:  Pediatr Nephrol       Date:  2006-01-05       Impact factor: 3.714

Review 2.  Concurrent FSGS and Hodgkin's lymphoma: case report and literature review on the link between nephrotic glomerulopathies and hematological malignancies.

Authors:  Abdalla Mallouk; Phuong-Thu T Pham; Phuong-Chi T Pham
Journal:  Clin Exp Nephrol       Date:  2006-12-20       Impact factor: 2.801

3.  Focal glomerulosclerosis in children: an Argentinian experience.

Authors:  A Tufro-McReddie; E Alvarez; E Arrizurieta; H Repetto
Journal:  Pediatr Nephrol       Date:  1992-03       Impact factor: 3.714

Review 4.  Treatment with cyclosporin of patients with idiopathic nephrotic syndrome.

Authors:  A Meyrier
Journal:  Springer Semin Immunopathol       Date:  1987

5.  Predictive factors of chronic kidney disease in primary focal segmental glomerulosclerosis.

Authors:  Marcelo M Abrantes; Luis Sergio B Cardoso; Eleonora M Lima; José M Penido Silva; José S Diniz; Eduardo A Bambirra; Eduardo A Oliveira
Journal:  Pediatr Nephrol       Date:  2006-05-30       Impact factor: 3.714

6.  Primary focal segmental glomerular sclerosis in children: clinical course and prognosis.

Authors:  Kyung Hoon Paik; Bum Hee Lee; Hee Yeon Cho; Hee Gyung Kang; Il Soo Ha; Hae Il Cheong; Dong-Kyu Jin; Kyung Chul Moon; Yong Choi
Journal:  Pediatr Nephrol       Date:  2006-10-21       Impact factor: 3.714

7.  Interstitial nephritis induced by protein-overload proteinuria.

Authors:  A A Eddy
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

8.  Kidney function in adults born with unilateral renal agenesis or nephrectomized in childhood.

Authors:  I Wikstad; G Celsi; L Larsson; P Herin; A Aperia
Journal:  Pediatr Nephrol       Date:  1988-04       Impact factor: 3.714

9.  Focal segmental glomerulosclerosis in children: comparison of nonedematous and edematous patients.

Authors:  S Roy; F B Stapleton
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

10.  Angiotensin converting enzyme inhibitors for reduction of proteinuria in children with steroid-resistant nephrotic syndrome.

Authors:  D S Milliner; B Z Morgenstern
Journal:  Pediatr Nephrol       Date:  1991-09       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.